From: Effect of food intake on 92 oncological biomarkers by the Proseek Oncology II panel
Variable | Fasting (n = 22) | 30 min after food intake (n = 21) | 120 min after food intake (n = 22) |
---|---|---|---|
Alpha-taxilin | 1.97 ± 0.37 | 1.84 ± 0.42 | 1.58 ± 0.47 |
Vascular endothelial growth factor A | 9.72 ± 0.53 | 9.64 ± 0.56 | 9.64 ± 0.62 |
Carboxypeptidase E | 2.43 ± 0.47 | 2.36 ± 0.43* | 2.24 ± 0.62 |
Kallikrein-13 | 3.27 ± 0.39 | 3.20 ± 0.48 | 3.22 ± 0.42 |
Carcinoembryonic antigen-related cell adhesion molecule 1 | 6.75 ± 0.15 | 6.73 ± 0.15 | 6.73 ± 0.17 |
Mesothelin | 4.61 ± 0.53 | 4.62 ± 0.54 | 4.67 ± 0.53 |
Tumor necrosis factor ligand superfamily member 13 | 7.19 ± 0.28 | 7.10 ± 0.28 | 7.10 ± 0.34 |
Pro-epidermal growth factor | 10.74 ± 0.24 | 10.13 ± 0.63* | 9.73 ± 0.70* |
Tumor necrosis factor receptor superfamily member 6B | 3.49 ± 0.49 | 3.51 ± 0.46 | 3.42 ± 0.72 |
Syndecan-1 | 6.24 ± 0.47 | 6.17 ± 0.50 | 6.23 ± 0.57 |
TGF-beta receptor type-2 | 6.58 ± 0.32 | 6.47 ± 0.30 | 6.53 ± 0.36 |
Interleukin-6 | 1.03 ± 1.16 | 1.01 ± 1.23 | 1.81 ± 1.20 |
CD48 antigen | 6.07 ± 0.27 | 5.99 ± 0.26 | 6.03 ± 0.40 |
Secretory carrier-associated membrane protein 3 | 1.67 ± 0.57 | 1.25 ± 0.47 | 1.02 ± 0.36* |
T-lymphocyte surface antigen Ly-9 | 4.58 ± 0.29 | 4.52 ± 0.28 | 4.58 ± 0.42 |
Interferon gamma receptor 1 | 3.52 ± 0.32 | 3.48 ± 0.33 | 3.50 ± 0.28 |
Integrin alpha-V | 2.28 ± 0.25 | 2.27 ± 0.26 | 2.27 ± 0.20 |
TNF-related apoptosis-inducing ligand | 6.83 ± 0.43 | 6.82 ± 0.40 | 6.86 ± 0.49 |
Kallikrein-11 | 4.95 ± 0.40 | 4.97 ± 0.38 | 4.77 ± 0.37 |
Glypican-1 | 3.83 ± 0.40 | 3.79 ± 0.38 | 3.82 ± 0.33 |
Tissue factor pathway inhibitor 2 | 6.36 ± 0.43 | 6.32 ± 0.40 | 6.46 ± 0.41 |
Kallikrein-8 | 6.27 ± 0.34 | 6.24 ± 0.34 | 5.98 ± 0.40 |
Vascular endothelial growth factor receptor 2 | 6.38 ± 0.18 | 6.34 ± 0.18 | 6.37 ± 0.20 |
Ly6/PLAUR domain-containing protein 3 | 3.59 ± 0.28 | 3.56 ± 0.30 | 3.57 ± 0.48 |
Podocalyxin | 2.98 ± 0.19 | 2.99 ± 0.18 | 3.02 ± 0.18 |
Protein S100-A4 | 3.64 ± 0.41 | 3.63 ± 0.52 | 3.40 ± 0.49 |
Insulin-like growth factor 1 receptor | 2.92 ± 0.29 | 2.83 ± 0.32 | 2.82 ± 0.33 |
Receptor tyrosine-protein kinase erbB-2 | 6.31 ± 0.24 | 6.26 ± 0.26 | 6.32 ± 0.38 |
Receptor tyrosine-protein kinase erbB-3 | 7.19 ± 0.24 | 7.15 ± 0.21 | 7.19 ± 0.24 |
Stem cell factor | 8.76 ± 0.32 | 8.80 ± 0.28 | 8.79 ± 0.29 |
SPARC | 5.88 ± 0.17 | 5.85 ± 0.18 | 5.83 ± 0.16 |
Granzyme H | 2.43 ± 0.56 | 2.11 ± 0.55* | 2.18 ± 0.76 |
Transforming growth factor alpha | 2.78 ± 0.49 | 2.70 ± 0.58 | 2.60 ± 0.50 |
Furin | 3.07 ± 0.36 | 2.96 ± 0.38 | 3.12 ± 0.41 |
Protein CYR61 | 4.27 ± 0.53 | 4.23 ± 0.51 | 4.33 ± 0.65 |
Kallikrein-14 | 5.46 ± 0.65 | 5.31 ± 0.67 | 5.19 ± 0.70 |
FAS-associated death domain protein | 2.06 ± 0.77 | 1.66 ± 0.73 | 1.22 ± 0.52* |
Methionine aminopeptidase 2 | 2.85 ± 0.87 | 2.79 ± 0.83* | 2.44 ± 0.61* |
Nectin-4 | 5.52 ± 0.35 | 5.40 ± 0.32* | 5.25 ± 0.49 |
Tumor necrosis factor ligand superfamily member 6 | 8.72 ± 0.36 | 8.67 ± 0.37 | 8.74 ± 0.44 |
Ephrin type-A receptor 2 | 1.11 ± 0.30 | 1.08 ± 0.32 | 1.06 ± 0.31 |
Integrin beta-5 | 6.33 ± 0.25 | 6.27 ± 0.26 | 6.28 ± 0.28 |
Galectin-1 | 4.76 ± 0.21 | 4.76 ± 0.21 | 4.68 ± 0.31 |
Seizure 6-like protein | 4.46 ± 0.24 | 4.46 ± 0.28 | 4.45 ± 0.29 |
Transmembrane glycoprotein NMB | 5.38 ± 0.16 | 5.36 ± 0.19 | 5.37 ± 0.18 |
Carbonic anhydrase 9 | 1.66 ± 0.56 | 1.77 ± 0.55 | 1.69 ± 0.75 |
Melanoma-derived growth regulatory protein | 9.32 ± 0.26 | 9.31 ± 0.26 | 9.26 ± 0.28 |
Cathepsin L2 | 2.80 ± 0.37 | 2.59 ± 0.30* | 2.59 ± 0.44 |
CD27 antigen | 7.52 ± 0.34 | 7.46 ± 0.34 | 7.50 ± 0.49 |
Xaa-Pro aminopeptidase 2 | 5.96 ± 0.47 | 5.90 ± 0.47 | 5.98 ± 0.53 |
Receptor tyrosine-protein kinase erbB-4 | 4.37 ± 0.23 | 4.31 ± 0.25 | 4.36 ± 0.34 |
Hepatocyte growth factor | 6.15 ± 0.54 | 6.06 ± 0.50 | 6.05 ± 0.52 |
Disintegrin and metalloproteinase domain-containing protein 8 | 4.10 ± 0.33 | 4.00 ± 0.29 | 3.96 ± 0.39 |
5′-Nucleotidase | 9.05 ± 0.31 | 8.95 ± 0.28 | 9.00 ± 0.34 |
Cyclin-dependent kinase inhibitor 1 | 0.52 ± 0.49 | 0.42 ± 0.48 | 0.21 ± 0.56 |
Delta-like protein 1 | 8.60 ± 0.31 | 8.57 ± 0.27 | 8.59 ± 0.34 |
Midkine | 5.11 ± 0.48 | 4.82 ± 0.63 | 4.80 ± 0.72 |
Tyrosine-protein kinase ABL1 | 1.56 ± 0.68 | 1.31 ± 0.69 | 1.13 ± 0.69 |
Fibroblast growth factor-binding protein 1 | 6.21 ± 0.26 | 6.19 ± 0.34 | 6.10 ± 0.37 |
Toll-like receptor 3 | 4.68 ± 0.57 | 4.64 ± 0.62 | 4.68 ± 0.68 |
Tyrosine-protein kinase Lyn | − 0.06 ± 0.19 | − 0.15 ± 0.21 | − 0.19 ± 0.25 |
Proto-oncogene tyrosine-protein kinase receptor Ret | 4.30 ± 0.47 | 4.24 ± 0.45 | 4.29 ± 0.43 |
Vimentin | 3.68 ± 0.37 | 3.49 ± 0.47 | 3.32 ± 0.49 |
Tumor necrosis factor receptor superfamily member 19 | 3.95 ± 0.41 | 3.90 ± 0.36 | 3.81 ± 0.54 |
Cornulin | 5.44 ± 1.16 | 5.46 ± 1.18 | 5.51 ± 0.99 |
T-cell leukemia/lymphoma protein 1A | 3.89 ± 0.82 | 3.78 ± 0.82 | 3.65 ± 0.90 |
CD160 antigen | 4.61 ± 0.35 | 4.55 ± 0.28 | 4.51 ± 0.53 |
Tumor necrosis factor receptor superfamily member 4 | 2.57 ± 0.40 | 2.51 ± 0.36 | 2.51 ± 0.45 |
MHC class I polypeptide-related sequence A and B | 2.60 ± 1.78 | 2.49 ± 1.80 | 2.56 ± 1.85 |
WNT1-inducible-signaling pathway protein 1 | 4.58 ± 0.60 | 4.48 ± 0.64 | 4.51 ± 0.59 |
VEGF-co regulated chemokine 1 | 1.69 ± 0.46 | 1.69 ± 0.51 | 1.70 ± 0.61 |
Pancreatic prohormone | 2.39 ± 0.79 | 4.29 ± 0.91* | 3.71 ± 1.22* |
Protein S100-A11 | 2.73 ± 0.36 | 2.62 ± 0.36 | 2.56 ± 0.46 |
Amphiregulin | 1.28 ± 0.46 | 1.26 ± 0.37 | 1.21 ± 0.41 |
Endothelial cell-specific molecule 1 | 7.99 ± 0.48 | 8.02 ± 0.47 | 8.09 ± 0.52 |
C-type lectin domain family 4 member K | 2.29 ± 0.34 | 2.22 ± 0.30 | 2.24 ± 0.45 |
ICOS ligand | 6.13 ± 0.38 | 6.00 ± 0.46 | 6.11 ± 0.39 |
WAP four-disulfide core domain protein 2 | 6.38 ± 0.32 | 6.36 ± 0.30 | 6.32 ± 0.40 |
C-X-C motif chemokine 13 | 8.26 ± 0.57 | 8.20 ± 0.51 | 8.32 ± 0.60 |
Mothers against decapentaplegic homolog 5 | 1.76 ± 0.46 | 1.80 ± 0.55 | 1.78 ± 0.56 |
A disintegrin and metalloproteinase with thrombospondin motifs 15 | 0.35 ± 0.43 | 0.45 ± 0.42 | 0.35 ± 0.52 |
CD70 antigen | 2.84 ± 0.35 | 2.87 ± 0.38 | 2.90 ± 0.55 |
R-spondin-3 | − 0.20 ± 0.36 | − 0.28 ± 0.36 | − 0.07 ± 0.53 |
Folate receptor gamma | 6.51 ± 1.69 | 6.48 ± 1.75 | 6.44 ± 1.75 |
Carcinoembryonic antigen-related cell adhesion molecule 5 | 1.45 ± 0.62 | 1.38 ± 0.70 | 1.48 ± 0.64 |
Vascular endothelial growth factor receptor 3 | 5.56 ± 0.25 | 5.54 ± 0.25 | 5.51 ± 0.31 |
Mucin-16 | 3.07 ± 0.85 | 3.12 ± 0.78 | 3.14 ± 0.92 |
Wnt inhibitory factor 1 | 5.23 ± 0.47 | 5.12 ± 0.42 | 5.16 ± 0.50 |
Granzyme B | 1.91 ± 0.81 | 1.75 ± 0.86 | 1.85 ± 0.90 |
Fc receptor-like B | − 0.39 ± 0.55 | − 0.33 ± 0.55 | − 0.38 ± 0.57 |
Annexin A1 | 1.93 ± 0.43 | 1.82 ± 0.47 | 1.69 ± 0.50 |
Folate receptor alpha | 5.83 ± 0.29 | 5.79 ± 0.28 | 5.81 ± 0.43 |